Joint Aad-Npf Guidelines Of Care For The Management Of Psoriasis With Systemic Non-Biological Therapies

Psoriasis is a chronic inflammatory disease involving multiple organ systems and affecting approximately 2% of the world ’s population. In this guideline, we focus the discussion on systemic, non-biologic medications for the treatment of this disease. We provide a detailed discussion of efficacy and safety for the most commonly used medications—including methotrexate, cyclosporine, and acitretin—and provide reco mmendations to assist prescribers in initiating and managing patients on these treatments.

Source: Journal of the American Academy of Dermatology - February 27, 2020 Category: Dermatology Authors: Alan Menter, Joel M. Gelfand, Cody Connor, April W. Armstrong, Kelly M. Cordoro, Dawn M.R. Davis, Boni E. Elewski, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Dario Kivelevitch, Neil J. Korman, Daniela Krosh Source Type: research